 Pneumococcal carriage among the sampled children was 31 % (244/775)  Penicillin non-susceptibility increased during 2013-2015 after PCV13 introduction 
Background
Streptococcus pneumoniae, or the pneumococcus, is still in the era of pneumococcal conjugate vaccines (PCVs) an important cause of bacterial pneumonia, sepsis and meningitis in children (Wahl, O'Brien et al. 2018) . Nasopharyngeal colonization of pneumococci is most common in pre-school children; it precedes infection and enables horizontal spread of the bacteria (Bogaert, De Groot et al. 2004 ). Children in low-income countries have the highest burden of colonization, which may be due to higher exposure to risk factors such as crowding (Abdullahi, Karani et al. 2012) .
High antibiotic use is associated with increased risk of nasopharyngeal carriage of penicillin non-A C C E P T E D M A N U S C R I P T susceptible pneumococci in children (Arason, Kristinsson et al. 1996; Kobayashi, Conklin et al. 2017; Melander, Molstad et al. 1998 ). According to the WHO Integrated Management of Childhood Illness oral amoxicillin is the drug of choice for treatment of childhood pneumonia at primary health care level (WHO 2014b) . Children aged 2 months -5 years presenting with fast breathing or chest indrawings, not improving after treatment with bronchodilator in the case of wheezing, are assumed to suffer from pneumonia and are eligible for antibiotic treatment (WHO 2014b ). An earlier study at paediatric health care facilities in Moshi, Tanzania, showed remarkably high prescription of antibiotics to children presenting with symptoms such as cough, but no signs of pneumonia (Gwimile, Shekalaghe et al. 2012 ).
The pneumococcal conjugate vaccine (PCV) was developed to generate an appropriate immune response in small children and so defend against the 7, 10 or 13 of the most disease-causing pneumococcal serotypes. In December 2012, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced into the national immunization program in Tanzania, and was given to children at 4, 8 and 12 weeks of age with no catch-up campaign at the time of enrolment (IVAC 2012) . The PCV13 has proved to dramatically reduce the incidence of invasive pneumococcal disease in children from the included serotypes (von Gottberg, de Gouveia et al. 2014; Cutts, Zaman et al. 2005) and to lower the incidence of radiologically proven pneumonia in South Africa and the Gambia (Klugman, Madhi et al. 2003; Cutts, Zaman et al. 2005 , Mackenzie, Hill et al. 2017 . Soon after introduction of the PCV10 in Kilifi, Kenya carriage of vaccine serotypes in children under 5 years of age decreased by 64 %, also proving herd-effect in older children and adults (Hammitt, Akech et al. 2014) . The proportional impact of the vaccine depends on serotype distribution prior to introduction of the vaccine. A study on healthy children in Dar es Salaam showed 63 % coverage of PCV13 in colonizing pneumococci prevaccination (Moyo, Steinbakk et al. 2012 ).
Both the 7-and 13-valent pneumococcal conjugate vaccines have been shown to reduce antibiotic-A C C E P T E D M A N U S C R I P T resistant invasive pneumococcal disease in countries such as South Africa, the US and Canada (Klugman, Madhi et al. 2003; Tomczyk, Lynfield et al. 2016; Tyrrell, Lovgren et al. 2009 ). However, the effect of PCV13 on antibiotic non-susceptibility in colonizing and/or invasive pneumococci is, in large parts of sub-Saharan Africa less known due to lack of routine culture and antibiotic susceptibility testing (Balsells, Guillot et al. 2017; Hackel, Lascols et al. 2013; Williams, Isaacs et al. 2018) .
Household air pollution due to incomplete combustion of solid fuels during cooking, heating or lighting has emerged as an important risk factor for childhood pneumonia (GBD 2015 LRI Collaborators 2017 Gordon, Bruce et al. 2014 ). Exposure to the toxic pollutants, such as particulate matter, has proved to affect the defence against microorganisms on all levels of the respiratory tract (Barregard, Sallsten et al. 2008; Gordon, Bruce et al. 2014; Hawley and Volckens 2013; Rylance, Fullerton et al. 2015; Zhou and Kobzik 2007) . Although less studied, household air pollution may also alter the colonizing microbes of the respiratory tract, including pneumococci, which may increase the risk of infection (Hussey, Purves et al. 2017; Rylance, Kankwatira et al. 2016 ).
This study aimed to determine antibiotic susceptibility and serotype/serogroup distribution of colonizing pneumococci in Tanzanian children during a three-year period shortly after the introduction of the PCV13 in Moshi, Tanzania. We further aimed to assess the epidemiology of pneumococcal carriage including its relation to household air pollution and antibiotic use.
Methods

Recruitment of children
Serial cross-sectional surveys were performed in October-November 2013, February-March 2014 and February-April 2015 in Moshi urban district, in the Kilimanjaro Region of northern Tanzania. In 2012, Moshi urban district had an estimated population of over 180,000 people (National Bureau of Statistics, Ministry of Finance 2013). The district had a total of 24 public health facilities; four hospitals, five health centres and 15 dispensaries. The samples were collected at six different health
facilities, chosen to represent different geographical locations within the wider district. These included both dispensaries (Bondeni, Njoro, Rau) and health centres (Pasua, Majengo, Shirimatunda) (Additional file 1). All children below two years of age attending study health facilities with their parent or guardian for medical attention including routine growth monitoring were invited to participate in the study. The parents or guardians responded to a questionnaire for socio-demographic information and health status of the child. Parents or guardians also responded to questions on antibiotic use; they were asked to give the name of the antibiotic used in order to avoid confusion with other medicines. If the patient's medical log was brought to the clinic, it was reviewed to compliment the parent/guardian's response. To determine air pollution on household level, parents or guardians participating in 2015 were asked additional questions such as use of stoves, cooking location and construction of the household building. Current weight and length of the child were recorded. Due to greater numbers of patients attending health centres in areas attributed by higher population density, a larger proportion of children per study year were sampled at Pasua and Majengo.
Specimen collection
A nasopharyngeal sample was collected from each child according to standard procedure (Satzke, Turner et al. 2013 ), using a Blue-cap E-swab (Copan Diagnostics Inc., Murrieta, USA). The samples were stored in a cool box and were brought to the Clinical Laboratory at Kilimanjaro Christian Medical Centre (KCMC), Moshi, Tanzania, for culture, all within six hours.
Isolation and identification of S. pneumoniae
At the KCMC laboratory, the samples were inoculated on goat blood agar (HiMedia, Mumbai, India) that were incubated at 37°C in sealed containers (Oxoid Limited, Hampshire, UK) along with a CO2 gas pack (BD GasPak TM EZ CO2 Container System) and a CO2 indicator (BD CO2 Indicator 0,5 mL)
for 16-20 hours, and a further 40-44 hours if no pneumococci were found at the first examination.
Identification of S. pneumoniae was based on colony morphology and optochin sensitivity (≥14 mm). (Finkelstein, Huang et al. 2003; Moyo, Steinbakk et al. 2012) .
Nucleic acid extraction and molecular characterization of the strains
Almost all pneumococcal isolates were found to be non-viable after storage and transport to Gothenburg. Further analyses were therefore performed by molecular methods for confirmation of species identification, and for determination of serotypes/serogroups. DNA was extracted from 100 µL of STGG storage medium containing the bacterial isolate diluted in 900 µL of phosphate buffered saline (PBS) using the MagNA Pure LC instrument (Roche Diagnostics, Mannheim, Germany) and Hauben et al. (Hauben, Vauterin et al., 1997) . A flow chart of the analyses performed is shown in Figure 1 .
Serotyping of S. pneumoniae
Initially, detection of 40 different serotypes was performed using a multiplex real-time PCR protocol published by Centers for Disease Control and Prevention (CDC) with slight modifications as previously described (Birindwa, Emgard et al. 2018) . For cpsA positive samples in which the serotype could not be detected by the multiplex PCR, the serotypes/serogroups were determined using a modified Sequetyping protocol (Birindwa, Emgard et al. 2018) . Briefly, two PCR reactions were set up to amplify the whole cpsB gene. The PCR products were sent to GATC Biotech (Cologne, Germany) for purification and sequencing using the four PCR primers. The 1006 bp sequence product was matched to a reference database for determination of the serotype/serogroup. Differentiation of serotype 6 was performed using a DNA sequencing-dependent approach (preprint available at https://www.biorxiv.org/content/early/2018/09/12/415422). A single nucleotide polymorphism (SNP) that distinguishes serotypes 6A/6C (guanine) and serotypes 6B/6D (adenine) in sequence nucleotide position 584 of the wciP region was detected. Subsequently, for differentiation of
serotype 6A and 6C a 6 bp deletion in the wzy gene was detected. Differentiation of serotype 6B and 6D was done by a single PCR analysis.
Those samples that did not carry the pneumococcal capsule genes cpsA and cpsB, but were positive for the "Xisco" gene, thus being non-encapsulated S. pneumoniae, were further analysed for the presence of the genes aliC and aliD. These genes are described as identification markers for nontypeable pneumococci according to Park et al. (Park, Kim et al. 2012) .
Statistics
Univariable and multivariable logistic regression were performed for determination of risk factors for pneumococcal carriage and for carriage of penicillin non-susceptible pneumococci in all included children. To determine whether changes in penicillin non-susceptibility were significant between the years, a multivariable logistic regression was performed for all carrier positive children. Risk factors described in former studies were considered covariates and were adjusted for in all multivariable models (Abdullahi, Karani et al. 2012; Arason, Kristinsson et al. 1996; Bogaert, De Groot et al. 2004; Kobayashi, Conklin et al. 2017; Melander, Molstad et al. 1998 ). The analyses were made using IBM SPSS Statistics v. 25, the significance of coefficients was tested for using Wald's test; p-values 0.05
were considered significant.
Results
Characteristics of the study population
Eight hundred parents or guardians were informed about the study, 23 of them refused to let their child participate and two were excluded because of young age of the parent or guardian (<18 years) leaving a total of 775 included children. Median age of the children was 8 months (range 0-24 months).
Socioeconomic and health information about the children are shown in Table 1 . The majority (73 %, n=562) were visiting the health facility for vaccination or routine growth monitoring whilst 23 %
(n=176) of the children were ill and were brought to be seen by a clinician. In total 78 % (608/775) of the children had received at least one dose of PCV13.
Antibiotic use in the children was high, 54 % (n=418) of the children had been treated with antibiotics in the past three months. Most antibiotics (87 %, 131/150) consumed within seven days prior to sampling were prescribed by a clinician ( Table 1 ). The most common reason for antibiotic use in the week preceding sampling was respiratory tract infection (76 %, 77/101, data from 2014-2015).
However, only one third (n=26) of the antibiotic treated children were reported to have had signs of fast or laboured breathing whilst two thirds (n=51) presented with cough and/or runny nose with or without fever according to the parent or guardian. Amoxicillin/ampicillin was the most commonly used antibiotic (Additional file 2).
The majority (85 %, n=658) of households included during the period 2013-2015 used solid fuel, i.e.
firewood or charcoal, for cooking (Table 1) . Most households included in 2015 (88 %, 188/213) reported to use more than one stove (Additional file 3: Table S1 ). The most commonly used stove was an improved charcoal stove, owned by a total of 165 (77 %) of the households, whilst 27 (13 %) relied mostly on a three-stone fire. About half of the households performed some cooking in the main living area (49 %, n=104) or outside (53 %, n=112). Kerosene or gas was predominantly used inside whilst charcoal was used both inside and outside (Additional file 3: Table S2 ). Most household buildings (75 %, n=160) were made of a material with high thermal mass such as adobe, baked bricks or concrete (Additional file 3: Table S1 ).
Nasopharyngeal carriage of S. pneumoniae in association to risk factors
The pneumococcal carriage rate among the sampled children was 31 % (244/775), as determined by optochin-susceptibility of isolated pneumococci at the KCMC laboratory in Tanzania. Both univariable and multivariable analyses showed that pneumococcal carriage increased significantly
with age and during respiratory tract infection (Table 2) . Neither type of fuel used for cooking, construction of the roof, nor material used to construct the walls showed any relation to carriage of S.
pneumoniae in the 2015 cohort (Additional file 3: Table S3 ).
Antimicrobial resistance patterns of S. pneumoniae
The antimicrobial susceptibility pattern was determined at the KCMC laboratory for the 244 pneumococcal isolates (Table 4) . Almost all isolates were non-susceptible to trimethoprimsulfamethoxazole (97 %, n=236). Nearly half of the pneumococcal isolates were resistant to oxacillin 
Risk factors for carriage of penicillin non-susceptible pneumococci
Having more siblings was found to be a risk factor for colonization of pneumococci with reduced susceptibility to penicillin in the univariable and multivariable analyses (Table 3) . Girls were more commonly colonized with penicillin non-susceptible pneumococci as shown in the multivariable analysis (Table 3) .
Molecular identification of S. pneumoniae
Of the 244 isolates identified as S. pneumoniae by optochin-susceptibility testing at the KCMC laboratory, 241 were further analysed by biomolecular testing in Gothenburg, Sweden (Figure 1 ). Two hundred and five (85%) isolates were confirmed to be S. pneumoniae by the presence of the cpsA gene.
Among the 36 isolates that were negative for the cpsA gene, 11 were further confirmed as noncapsulated or non-typeable S. pneumoniae by the presence of the "Xisco" and the aliC/aliD genes. In the remaining 25 samples, no PCR amplification could be achieved, possibly due to degradation of bacterial DNA during storage and transport.
Serotype distribution
The serotypes or serogroups were determined in 175/205 of the pneumococcal isolates analysed by multiplex real-time PCR or by the modified Sequetyping protocol, both performed in Gothenburg, Sweden ( Figure 1 ). In seven of theses samples more than one serotype/serogroup was detected. Thus, a total of 183 serotypes/serogroups were identified. Eleven additional isolates were found to be nonencapsulated, and hence non-typeable (Figure 1 ). The combined results of the 194 identified serotypes/serogroups (including non-typeable) from a total of 186 pneumococcal isolates are shown in Figure 3 .
The most prevalent serogroup was 6, present in 22 % (41/186) of the samples. Among the serogroup 6 isolates, 18 were further identified as serotype 6B and nine as serotype 6A, whereas the remaining 14 samples could not be subjected to further analysis due to low DNA concentration. The second most common serotype/serogroup was 15B/C which was present in 11 % (21/186) of the isolates followed 
Discussion
This study has explored carriage of S. pneumoniae in children under two years of age residing in
Moshi, Tanzania during a three-year period directly after introduction of the PCV13. Studies on the carriage rates of S. pneumoniae in healthy subjects are important in order to understand the dynamics of the population with respect to antibiotic resistance and serotype distribution. In our study, the pneumococcal carriage detected by culture was 31 %, which is in accordance with a previous study in Dar es Salaam, Tanzania, reporting a 35 % pre-vaccination pneumococcal carriage rate (Moyo, Steinbakk et al. 2012) , and in Ghana, where the pneumococcal carriage among children was 34 % (Dayie, Arhin et al. 2013) . However, similar studies in other regions of Africa have reported higher pneumococcal carriage both pre-and post-vaccination (Hammitt, Akech et al. 2014 , Kobayashi, Conklin et al. 2017 Mills, Twum-Danso et al. 2015; Dube, Ramjith et al. 2018; Adetifa, Antonio et al. 2012 ). This variation can be attributed to differences in the study populations and consequently more or less exposure to risk factors as well variances in the detection methods (Bogaert, De Groot et Satzke, Turner et al. 2013 ). For example, we did not use STGG medium for nasopharyngeal swab transport as recommended (Satzke, Turner et al. 2013) , which may have led to the loss of viable pneumococci between sampling and culture. However, such loss would most likely be randomly spread between antibiotic susceptible and non-susceptible strains and should thus not affect the main results of this study.
The higher rate of pneumococcal colonization in children with signs of respiratory tract infection corroborates previous epidemiological studies (Abdullahi, Karani et al. 2012; Mills, Twum-Danso et al. 2015) , as well as experimental studies performed in mice models that showed an increased adhesion of S. pneumoniae to epithelial cells after viral infection (Nita-Lazar, Banerjee et al. 2015; Smith, Sandrini et al. 2014 ). Our results also confirm an increase of pneumococcal carriage before the age of 2 years as previously reported (Abdullahi, Karani et al. 2012; Bogaert, De Groot et al. 2004 ). Among risk factors associated with pneumococcal carriage, exposure to household air pollution has shown to be relevant (Gordon, Bruce et al. 2014) . Households included in our study would typically rely on several different fuels, stoves and locations for cooking which may vary according to changing needs or seasonal variations. Exposure to household air pollution induce inflammation of the respiratory tract and has been associated with pneumococcal colonization in epidemiological studies (Gordon, Bruce et al. 2014; Rylance, Kankwatira et al. 2016 ) as well as in experimental studies in vitro and in mice (Hussey, Purves et al. 2017 ). In our study there was no significant association between pneumococcal carriage and use of solid fuels, however, very few households relied on clean fuels only. Investigating possible effects of household air pollution on colonizing microbes in vivo is complex. We thus suggest future studies to include individual measurements of smoke exposure (Gordon, Bruce et al. 2014 ).
Knowledge of antimicrobial use and susceptibility in human pathogens in Eastern Africa is limited. In our study, we report a significant increase of penicillin non-susceptible pneumococci carried by (Moyo, Steinbakk et al. 2012; Bles, de Mast et al. 2015) . However, this is in line with the situation in Ghana after introduction of the PCV13 (Dayie, Arhin et al. 2013) . It is possible that penicillin non-susceptibility in healthy children in northern Tanzania was higher prior to introduction of the PCV13, as indicated by previous studies, and decreased as a result of the vaccine introduction. However, the number of isolates in Dar es Salaam (Moyo, Steinbakk et al. 2012) and Moshi (Bles, de Mast et al. 2015) was small and in Moshi the sampled children were born to HIV-positive mothers, this group possibly being more exposed to antibiotics due to increased sensitivity to infection. In addition, our sampling started shortly after the PCV13 introduction, and a dramatic drop in non-susceptibility of carried pneumococci is less likely to occur soon after the vaccine implementation.
Increased number of siblings was found to be an independent risk factor for carriage of pneumococci with reduced susceptibility to penicillin, this being closely related to previously reported factors such as crowding and day-care attendance (Kristinsson 1997) . Girls were also more commonly colonized with penicillin non-susceptible pneumococci as shown in the multivariable model. As far as we know this has only been shown in one previous study conducted in Israel (Yagupsky, Porat et al. 1998 In our study, non-susceptibility to erythromycin was higher (15 %) compared to studies in Dar es
Salaam and in Moshi in 2010 that reported 6.0 % and 3.8 % of non-susceptibility, respectively (Moyo, Steinbakk et al. 2012; Bles, de Mast et al. 2015) . This results implies an increase of almost fourthfold for pneumococci non-susceptible to erythromycin in Moshi in the last years. Macrolides, such as erythromycin, are commonly used in adults and children to treat acute lower respiratory tract infections since it is also effective against atypical agents such as Mycoplasma pneumoniae and Legionella spp (Ministry of Health and Social Welfare 2013). In our study, erythromycin was the third most commonly used antibiotic in the children after amoxicillin and trimethoprim-sulfamethoxazole. In addition, we also show high pneumococcal resistance to trimethoprim-sulfamethoxazole (97 %), which is similar to several studies from the region (Bles, de Mast et al. 2015; Kobayashi, Conklin et al. 2017; Moyo, Steinbakk et al. 2012 ). This antibiotic was previously considered as a first-line treatment for pneumonia, and usage of this antibiotic is still common for treatment of respiratory infections, probably due to persisting treatment traditions. Moreover, trimethoprim-sulfamethoxazole is widely used as a prophylactic treatment in HIV-exposed infants and HIV-positive individuals in resourcelimited settings (WHO 2014a).
High use of prescribed antibiotics was observed during the study. A large majority of children (87 %) treated during the week prior to sampling were receiving the antibiotic through prescription by a clinician. However, only one third of the children in whom antibiotics were prescribed for respiratory tract symptoms presented fast or laboured breathing, i.e. signs of pneumonia which indicates need for antibiotics, according to their parent or guardian. These results confirm previous findings of inappropriate prescribing practices by physicians in Moshi (Gwimile, Shekalaghe et al. 2012 ) which
could be affected by perceived patient demand and be linked to cultural habits (Radyowijati and Haak 2003) .
All information on antibiotic prescription and use was collected from the parent/guardian and complimented by reviewing the child's medical log when possible. Effort was put on avoiding confusion with other medicines by asking for the name of the antibiotic. Rates of antibiotic use based solely on parental recall is often underestimated, as shown by previous studies comparing parents'
reported use of antibiotics with detected antibiotics in the urine of the child (Driscoll, Bhat et al. 2012; Khennavong, Davone et al. 2011; Sombrero, Sunico et al. 1999) . Moreover, high use and miss-use of antibiotics in the community is one of the drivers of increased antibiotic resistance. Thus, although there is uncertainty in the reported use of antibiotics, there are reasons to believe a more rational use of antibiotics in children in northern Tanzania is of major public health importance.
In our study, serotype/group 6, 19F, 23F and 14 were the most prevalent serotypes/serogroups of those included in PCV13. These serotypes are considered colonisers and tend to be carried within the nasopharynx for prolonged periods of time compared with more invasive and immunogenic serotypes such as serotypes 1 and 3 (Dube, Ramjith et al. 2018; Sleeman, Griffiths et al. 2006) . Among the non-PCV13 serotypes/groups 15B/C, 19B and 10A were the most prevalent. Serotype/group 15B/C has been reported as one of the predominant serotypes/groups recovered after PCV13 in both low and high-income countries (Devine, Cleary et al. 2017; Ho, Chiu et al. 2015; Dube, Ramjith et al. 2018 ).
Other studies in Africa have reported a high prevalence of serotype/group 15B/C, 10A, 11 and 19A (Birindwa, Emgard et al, 2018; Kwambana-Adams, Hanson et al. 2017; Dube, Ramjith et al. 2018 ).
However, the relative high prevalence of serotype 19B in this study was unexpected and has to our knowledge not been reported in other recently published African studies.
Apart from protecting vulnerable subjects from invasive pneumococcal disease, the PCV13 was also designed to target some serotypes more commonly associated with high non-susceptibility (Kyaw, Lynfield et al. 2006) . Following introduction of PCV, a change from PVC-serotypes to non-PCV serotypes in the colonization of the nasopharynges has been shown (Croucher, Finkelstein et al. 2013; Hammitt, Akech et al. 2014) , which was also demonstrated in this study. In the PCV era, colonizing pneumococci is thus exposed to selective pressure from both the vaccine and administered antibiotics.
This may consequently select for those resistant strains not included in the vaccine (Danino, GivonLavi et al. 2018; Croucher, Chewapreecha et al. 2014; Keenan, Klugman et al. 2015) . In line with this, our study shows a notable increase of pneumococci with reduced susceptibility to penicillin among non-PCV13 serotypes in 2015 (50 %) compared to 2013 (19 %). This highlights the need for continued surveillance of serotype distribution in colonization and disease, in association with antibiotic susceptibility, also after vaccine implementation. The second most common non-PCV13 serotype was unexpectedly 19B, of which almost all were non-susceptible to penicillin (12 out of 13). Unfortunately, further analysis of possible clonality among these isolates could not be performed due to scarce supply of genetic material.
Conclusions
Penicillin non-susceptibility increased in colonizing S. pneumoniae in northern Tanzania during a three-year period soon after introduction of the PCV13 vaccine. However, non-susceptibility to amoxicillin/ampicillin and ceftriaxone was still low. Measures to ensure rational use of antibiotics and more effective systems for surveillance of antibiotic resistance and serotype distribution are needed to assure continued effectual treatment of pneumococcal disease.
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